Obat
PrivateLast Round
Series A
Nov 23, 2023
Total Funding Raised
$19.06M
Company Overview
Obat operates in Enterprise Software and is based in Nantes. Its latest recorded funding round was a Series A round in November 2023.
Obat is a SaaS company that develops invoicing and payment software intended to serve small and medium enterprises in the construction industry.
Sector
Enterprise Software
Verticals
Construction Tech, Vertical SaaS, Project Management, Accounting & Expense, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Obat Comparables
Compare Obat with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Graneet | 89% | |
| Costructor | 88% | |
| Vertuoza | 87% |
For institutional investors. Book with your work email.
Obat Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 23, 2023 | ||||
| Seed | Sep 15, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Obat Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kima Ventures | Series A |
| New Alpha Asset Management | Series A |
| Holnest | Seed, Series A |
| NCI | Series A |
| Crédit Mutuel Innovation | Series A |
| Evolem | Seed, Series A |
| Bpifrance | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 23, 2023
$13M round led by Crédit Mutuel Innovation, NCI, New Alpha Asset Management, and Kima Ventures.
- Sep 15, 2022
$6M round led by Truffle Capital.
For institutional investors. Book with your work email.
Obat Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Obat's valuation, stock price, and market status.
Is Obat a public or private company?
Obat is a private company.
What is the current stock price of Obat?
Obat is a private company, so its shares have no public market price. Caplight tracks Obat's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Obat worth (valuation)?
Valuation information for Obat is not publicly available.
Can I buy Obat stock?
Obat shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Obat's last funding round?
Obat's most recent funding round was Series A on November 23, 2023.
Who are the main investors in Obat?
Key investors in Obat include Kima Ventures, New Alpha Asset Management, NCI, Crédit Mutuel Innovation, Truffle Capital.
Will Obat IPO soon?
No public IPO plans have been announced for Obat.
How can I track Obat secondary market activity?
Caplight tracks bids, offers, and trades in Obat's shares on secondary markets.